Cargando…

The Tumorigenic Potential of Human Pluripotent Stem Cells

Human pluripotent stem cells (hPSCs) are currently evaluated for clinical applications due to their proliferation and differentiation capacities, raising the need to both assess and enhance, the safety of hPSC-based treatments. Distinct molecular features contribute to the tumorigenicity of hPSCs, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lezmi, Elyad, Benvenisty, Nissim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397652/ https://www.ncbi.nlm.nih.gov/pubmed/35679163 http://dx.doi.org/10.1093/stcltm/szac039

Ejemplares similares

Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells
por: Avior, Yishai, et al.
Publicado: (2017)

The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation
por: Lezmi, Elyad, et al.
Publicado: (2020)

Genome-wide Screen for Culture Adaptation and Tumorigenicity-Related Genes in Human Pluripotent Stem Cells
por: Weissbein, Uri, et al.
Publicado: (2019)

Identifying regulators of parental imprinting by CRISPR/Cas9 screening in haploid human embryonic stem cells
por: Bar, Shiran, et al.
Publicado: (2021)

Large-scale analysis of imprinting in naive human pluripotent stem cells reveals recurrent aberrations and a potential link to FGF signaling
por: Keshet, Gal, et al.
Publicado: (2021)

TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas
por: Avior, Yishai, et al.
Publicado: (2015)

Genome maintenance in pluripotent stem cells
por: Weissbein, Uri, et al.
Publicado: (2014)

Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells
por: Weissbein, Uri, et al.
Publicado: (2017)

Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements
por: Braverman-Gross, Carmel, et al.
Publicado: (2021)

Glypican 4 down-regulation in pluripotent stem cells as a potential strategy to improve differentiation and to impair tumorigenicity of cell transplants
por: Dono, Rosanna
Publicado: (2015)

Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells
por: Halevy, Tomer, et al.
Publicado: (2014)

Global Indiscriminate Methylation in Cell-Specific Gene Promoters following Reprogramming into Human Induced Pluripotent Stem Cells
por: Nissenbaum, Jonathan, et al.
Publicado: (2013)

The essentiality landscape of cell cycle related genes in human pluripotent and cancer cells
por: Viner-Breuer, Ruth, et al.
Publicado: (2019)

Identification of Novel Imprinted Differentially Methylated Regions by Global Analysis of Human-Parthenogenetic-Induced Pluripotent Stem Cells
por: Stelzer, Yonatan, et al.
Publicado: (2013)

Neural stemness unifies cell tumorigenicity and pluripotent differentiation potential
por: Zhang, Min, et al.
Publicado: (2022)

Induced pluripotent stem cells are induced pluripotent stem cell-like cells
por: Song, Liting, et al.
Publicado: (2015)

Studying Early Lethality of 45,XO (Turner's Syndrome) Embryos Using Human Embryonic Stem Cells
por: Urbach, Achia, et al.
Publicado: (2009)

Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells
por: Mayshar, Yoav, et al.
Publicado: (2011)

Large-Scale Analysis of X Inactivation Variations between Primed and Naïve Human Embryonic Stem Cells
por: Sarel-Gallily, Roni, et al.
Publicado: (2022)

Ladostigil Attenuates Induced Oxidative Stress in Human Neuroblast-like SH-SY5Y Cells
por: Zohar, Keren, et al.
Publicado: (2021)

Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells
por: Mahajani, Sameehan, et al.
Publicado: (2020)

ISSCR standards for the use of human stem cells in basic research
por: Ludwig, Tenneille E., et al.
Publicado: (2023)

History and current status of clinical studies using human pluripotent stem cells
por: Kobold, Sabine, et al.
Publicado: (2023)

Genome-wide loss-of-function screen using human pluripotent stem cells to study virus-host interactions for SARS-CoV-2
por: Pagis, Ariel, et al.
Publicado: (2023)

Generation, genomic characterization, and differentiation of triploid human embryonic stem cells
por: Haim-Abadi, Guy, et al.
Publicado: (2023)

Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
por: Mummery, Christine L.
Publicado: (2018)

An efficient SCNT technology for the establishment of personalized and public human pluripotent stem cell banks
por: Lee, Jeoung Eun, et al.
Publicado: (2016)

Perspective on human pluripotent stem cell‐derived cardiomyocytes in heart disease modeling and repair
por: Li, Qiang, et al.
Publicado: (2020)

ISSCR guidelines for the transfer of human pluripotent stem cells and their direct derivatives into animal hosts
por: Hyun, Insoo, et al.
Publicado: (2021)

Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research
por: Mascetti, Victoria L., et al.
Publicado: (2016)

Turning Potential Into Action: Using Pluripotent Stem Cells to Understand Heart Development and Function in Health and Disease
por: Fonoudi, Hananeh, et al.
Publicado: (2017)

A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells
por: Kurtz, Andreas, et al.
Publicado: (2018)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
por: Yiangou, Loukia, et al.
Publicado: (2020)

Human induced pluripotent stem cell based in vitro models of the blood-brain barrier: the future standard?
por: Neuhaus, Winfried
Publicado: (2017)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
por: Bono, Federica, et al.
Publicado: (2017)

Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells
por: Dressel, Ralf
Publicado: (2011)

Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic Perspectives
por: Tan, Yuan, et al.
Publicado: (2014)

“Mouse Clone Model” for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells
por: Zhang, Gang, et al.
Publicado: (2015)

Studying neurological disorders using induced pluripotent stem cells and optogenetics
por: Chin, Eunice W.M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iq850jg50o9l9c98se7n9tho1a